Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension

Humbert, 2004, Treatment of pulmonary arterial hypertension, N Engl J Med, 351, 1425, 10.1056/NEJMra040291

D'Alonzo, 1991, Survival in patients with primary pulmonary hypertension. Results from a national prospective registry, Ann Intern Med, 115, 343, 10.7326/0003-4819-115-5-343

Benza, 2010, Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL), Circulation, 122, 164, 10.1161/CIRCULATIONAHA.109.898122

Benza, 2008, Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension, J Am Coll Cardiol, 52, 1683, 10.1016/j.jacc.2008.08.033

Champion, 2009, Comprehensive invasive and noninvasive approach to the right ventricle pulmonary circulation unit: State of the art and clinical and research implications, Circulation, 120, 992, 10.1161/CIRCULATIONAHA.106.674028

Bradlow, 2010, Measuring the heart in pulmonary arterial hypertension (PAH): Implications for trial study size, J Magn Reson Imaging, 31, 117, 10.1002/jmri.22011

Blyth, 2005, Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension, Eur Heart J, 26, 1993, 10.1093/eurheartj/ehi328

McCann, 2007, Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension, Am J Roentgenol, 188, 349, 10.2214/AJR.05.1259

Sanz, 2007, Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension, Am J Cardiol, 100, 731, 10.1016/j.amjcard.2007.03.094

Junqueira, 2009, Myocardial delayed enhancement in patients with pulmonary hypertension and right ventricular failure: Evaluation by cardiac MRI, Br J Radiol, 82, 821, 10.1259/bjr/28241773

Shehata, 2011, Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling, AJR Am J Roentgenol, 196, 87, 10.2214/AJR.09.4114

Badesch, 2007, Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines, Chest, 131, 1917, 10.1378/chest.06-2674

Sinmonneau, 2004, Clinical classification of pulmonary hypertension, J Am Coll Cardiol, 43, 5S, 10.1016/j.jacc.2004.02.037

Lorenz, 1999, Normal human left and right ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging, J Cardiovasc Magn Reson, 1, 7, 10.3109/10976649909080829

Patterson, 1972, Treadmill exercise in assessment of the functional capacity of patients with cardiac disease, Am J Cardiol, 30, 757, 10.1016/0002-9149(72)90151-8

Gomberg-Maitland, 2007, Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension, J Heart Lung Transplant, 26, 732, 10.1016/j.healun.2007.04.013

Gulati, 2005, The prognostic value of a nomogram for exercise capacity in women, N Engl J Med, 353, 468, 10.1056/NEJMoa044154

Morris, 1993, Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men, J Am Coll Cardiol, 22, 175, 10.1016/0735-1097(93)90832-L

Bax, 2010, MIX 2.0. Professional software for meta-analysis in Excel

Shah, 2009, Value of exercise stress testing in the risk stratification of patients with pulmonary hypertension, Circ Heart Fail, 2, 278, 10.1161/CIRCHEARTFAILURE.108.807826

van Wolferen, 2007, Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension, Eur Heart J, 28, 1250, 10.1093/eurheartj/ehl477

Zafrir, 2007, Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome, Int J Cardiovasc Imaging, 23, 209, 10.1007/s10554-006-9140-5

Kawut, 2005, New predictors of outcome in idiopathic pulmonary arterial hypertension, Am J Cardiol, 95, 199, 10.1016/j.amjcard.2004.09.006

Gomez, 2001, Right ventricular ischemia in patients with primary pulmonary hypertension, J Am Coll Cardiol, 38, 1137, 10.1016/S0735-1097(01)01496-6

Moon, 2004, The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy, J Am Coll Cardiol, 43, 2260, 10.1016/j.jacc.2004.03.035

Bradlow, 2010, Understanding late gadolinium enhancement in pulmonary hypertension, Circ Cardiovasc Imaging, 3, 501, 10.1161/CIRCIMAGING.109.919779